To determine the combined effect of the rs2853669 (−245T > C) and TERT promoter mutation (−124C > T or −146C > T) on liver cancer survival rates, we first analyzed the overall survival rates of a Korean HCC patient cohort (SMH cohort, n = 93; Figure 1A, 1B). This evidence concerns the gene TERT and hepatocellular carcinoma.